Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
VolitionRX ( (VNRX) ) has shared an announcement.
Belgian Volition SRL has renewed its commitment to Dr. Gaetan Michel as CEO with a new employment agreement that includes a monthly wage, bonuses, and a severance package in line with Belgian Law. Concurrently, Volition Global Services has amended its consulting agreement with 3F Management to continue leveraging Dr. Michel’s expertise, providing a monthly fee and performance-related bonuses. These new arrangements secure Dr. Michel’s leadership roles across various subsidiaries and ensure his compensation remains in line with previous figures, underlining the company’s strategic continuity and leadership stability.
For a thorough assessment of VNRX stock, go to TipRanks’ Stock Analysis page.